+17.1%
CDNS vs MRNA
+27.9%
-10.8%
-31.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.1% | +0.7% | -0.6% | +0.1% |
| 7D | -6.5% | -8.2% | +1.7% | -6.3% |
| 30D | -13.0% | +125.6% | -138.6% | -18.0% |
| 3M | -26.0% | +197.1% | -223.1% | -33.1% |
| 6M | -2.8% | +148.5% | -151.3% | -10.4% |
| YTD | -8.8% | +363.3% | -372.1% | -22.6% |
| 1Y | -15.8% | +462.0% | -477.8% | -30.9% |
| All | +17.1% | +27.9% | -10.8% | +5.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling